Kellerhals Carrard has advised the shareholders of Hipp Technology Group AG and Endura AG. An investor group represented by Endura AG has sold a majority stake...
Sale of Majority Stake in Hipp Technology Group to Deutsche Beteiligungs AG
HAYA Therapeutics SA’s $65 Million Series A Funding Round
Lenz & Staehelin acted for Eli Lilly; Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital; VISCHER acted for HAYA Therapeutics AG. Wilson Sonsini Goodrich &...
TecMed AG’s CHF420 Million Acquisition Of Ypsomed Diabetes Care AG
Kellerhals Carrard advised TecMed on the deal, while Walder Wyss advised Ypsomed. TecMed is taking a step towards becoming a global diabetes care leader fully focused...



























